- Have any question?
- +995599096730
- neurogeorgia@gmail.com
At the International Center for Neuroscience Research, our Brain Aging and Dementia group is dedicated to advancing the diagnosis and treatment of Alzheimer’s disease and other neurodegenerative disorders through collaboration with other institutes and centers. Our research integrates fundamental scientific studies on the molecular and genetic roots of neurodegeneration, neuropathological analysis, sophisticated brain imaging, and both observational and clinical trials of approved and experimental drugs and natural supplements. We are committed to research and education in healthy brain aging, mild cognitive impairment, Alzheimer’s disease, Lewy body dementia, frontotemporal dementia, and other related conditions. Our work has enabled the identification of new biomarkers and neuroimaging methods, paving the way for more effective early interventions and therapeutic strategies.
Currently, an estimated 55 million people around the world are living with Alzheimer’s disease or another form of dementia a number projected to double every 20 years as populations age and life expectancy rises. Presently, there are no effective treatments, and the economic burden is unsustainable; in the United States alone, the cost of caring for individuals with Alzheimer’s disease is expected to approach $1.1 trillion by 2050.
our mission at the International Center for Neuroscience Research is to transform the landscape of brain aging through groundbreaking, collaborative science. We invite passionate researchers from every field related to neuroscience, medicine, engineering, computer science, and beyond to join us in this urgent endeavor together, we can create the breakthroughs that will change lives and secure a healthier future for millions facing Alzheimer’s disease and related conditions.
The center brings together faculty expertise and resources across neuroscience, genetics, investigative medicine, engineering, computer science, economics, chemistry, and artificial intelligence.
Achieving a comprehensive systems approach to unravel the mysteries of the aging brain and deliver foundational research that enables the creation of new tools to meet the challenges of brain aging
To determine pathways of brain aging, Identify risk and protective factors, develop strategies to prevent cognitive decline, understand behavioral and functional manifestations, and discover biomarkers
Dr. Nasrollah Moradikor, Ph.D., is currently Principal Investigator and Head of Brain Aging and Dementia at the International Center for Neuroscience Research in Georgia. Dr. Nasrollah has demonstrated exceptional leadership skills in promoting applied neuroscience research and establishing fruitful collaborations among scientists worldwide. In 2021, Dr. Nasrollah founded a new community platform named “Neuroscience Network” to support and develop neuroscience in the world. His ability to create a supportive and intellectually stimulating environment has been instrumental in promoting the development of aspiring neuroscientists. He has over 15 years of research and teaching experience and till now he has chaired many national and international events in the area of neuroscience. Nasrollah has been on the scientific advisory board and evaluation committees of several institutions abroad.
Collaborating Faculty
Collaborating Faculty
Collaborating Faculty
Collaborating Faculty
Affiliated Researcher
Affiliated Researcher
Affiliated Researcher
Affiliated Researcher
Affiliated Researcher
Professor International Islamic University Malaysia, Malaysia
Professor Osaka University, Japan
Professor University of Leeds, UK
Professor Ilia State University, Georgia
Professor Alalamein International University, Egypt
Professor Pasteur Institute of Tunisia, Tunisia
Our studies have revealed novel targets for drug development and led to promising therapeutic candidates. Additional patented compounds are currently being evaluated further both within our center and in collaboration with industry partners. Our research has offered new insights into disease processes and has led to the emerging use of these proteins as valuable disease biomarkers. Through collaboration with the Laboratories for Molecular Neuroscience, we are also investigating the multifactorial origins of progressive synaptic dysfunction in Alzheimer’s disease. We support a wide range of therapeutic research, from basic studies of disease mechanisms to early-stage clinical trials, including innovative approaches that repurpose existing medications. Research without clear therapeutic applications falls outside our funding priorities.
If you have questions about the group, please contact us
